EPG Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,522
Closed -$227K 449
2024
Q1
$227K Buy
2,522
+2
+0.1% +$169 0.06% 243
2023
Q4
$210K Buy
+2,520
New +$189K 0.06% 235
2023
Q1
Sell
-2,640
Closed -$208K 414
2022
Q4
$208K Buy
+2,640
New +$198K 0.08% 208
2022
Q3
Sell
-2,654
Closed -$213K 382
2022
Q2
$213K Buy
2,654
+19
+0.7% +$1.49K 0.09% 203
2022
Q1
$200K Buy
+2,635
New +$209K 0.07% 237
2020
Q2
Sell
-465
Closed -$31K 237
2020
Q1
$31K Buy
465
+1
+0.2% +$71 0.02% 337
2019
Q4
$32K Buy
+464
New +$31.6K 0.02% 282

Other funds holding CL

EPG Wealth Management's CL Position: Q2 2024 in Review

EPG Wealth Management sold out of Colgate-Palmolive (CL) in Q2 2024, closing a stake of 2,522 shares — an estimated $227K sold.

EPG Wealth Management first reported a position in CL in Q4 2019 and held it in 7 quarters. The position peaked at $227K in Q1 2024. 1,819 funds tracked by Wall St. Rank hold CL as of Q2 2024.

  • EPG Wealth Management reported no remaining Colgate-Palmolive position as of Q2 2024 after selling out during the quarter.
  • EPG Wealth Management sold 2,522 Colgate-Palmolive shares in Q2 2024, an estimated $227K.
  • EPG Wealth Management first reported a position in Colgate-Palmolive in Q4 2019 and held it in 7 quarters.
  • EPG Wealth Management's Colgate-Palmolive position peaked at $227K in Q1 2024.
  • 1,819 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2024.

Based on EPG Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.